Breaking News
Why Gardeners Are Wrong About Clay Soil
Majara Hotel Hormuz Island...
Stocks reach new lows as War goes on – Dow Jones and US Stock Market Outlook
Trump Goes Amalek on Iran: Israelization of The US Military; Gazafication of Iran & Lebanon
Top Tech News
The Secret Spy Tech Inside Every Credit Card
Red light therapy boosts retinal health in early macular degeneration
Hydrogen-powered business jet edges closer to certification
This House Is 10 Feet Underground and Costs $0 to Cool. Why Is It Banned in 30 States?
Cold Tolerant Lithium Battery?? Without Heaters!? Ecoworthy Cubix 100 Pro!
DLR Tests Hydrogen Fuel for Aviation at -253°C
Watch: China Claims Cyborg Breakthrough To Build An "Army Of Centaurs"
Instant, real-time video AI is now upon us, for better and worse
We Build and Test Microwave Blocking Panels - Invisible to Radar
Man Successfully Designs mRNA Vaccine To Treat His Dog's Cancer
Finally Confirmed! Vitamin D Nearly Abolishes ICU Risk in COVID-19
The First Randomized Controlled Trial on Vitamin D and COVID-19
The trial was conducted at the Reina Sofi?a University Hospital in Co?rdoba, Spain. The trial included 76 patients with COVID-19 pneumonia. Although this is no longer the standard of care, all patients were treated with hydroxychloroquine and azithromycin and, when needed, a broad-spectrum antibiotic. Admission to the ICU was determined by a multidisciplinary committee consisting of intensive care specialists, pulmonologists, internal medicine specialists, and members of the ethics committee.
The patients were randomly allocated to receive or not receive vitamin D in a 2:1 ratio. This resulted in 50 patients in the vitamin D group and 26 patients in the control group.